AJANTA PHARMA LTD FDA Approval ANDA 212234

ANDA 212234

AJANTA PHARMA LTD

FDA Drug Application

Application #212234

Application Sponsors

ANDA 212234AJANTA PHARMA LTD

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 450MG BASE0VALGANCICLOVIR HYDROCHLORIDEVALGANCICLOVIR HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-12-26STANDARD
LABELING; LabelingSUPPL7AP2021-06-04STANDARD
LABELING; LabelingSUPPL9AP2021-06-04STANDARD
LABELING; LabelingSUPPL19AP2022-08-22STANDARD

Submissions Property Types

ORIG1Null7
SUPPL7Null15
SUPPL9Null15
SUPPL19Null7

TE Codes

001PrescriptionAB

CDER Filings

AJANTA PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212234
            [companyName] => AJANTA PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"VALGANCICLOVIR HYDROCHLORIDE","activeIngredients":"VALGANCICLOVIR HYDROCHLORIDE","strength":"EQ 450MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/26\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-12-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.